Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01544088 · ClinicalTrials.gov registry record · NA

Group Treatment for PTSD: A Randomized Clinical Trial With Veterans

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
198
Enrollment target

NCT01544088: Completed NA study, sponsored by VA Office of Research and Development.

NCT01544088 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 198 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01544088, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
198 participants
Enrollment target

Study Summary

The purpose of this study is to examine whether group cognitive behavioral treatment (GCBT) is efficacious in the treatment of PTSD in a sample of male Veterans. Veterans with a primary diagnosis of chronic PTSD will be randomly assigned to either GCBT or a supportive group treatment condition. Both treatments will consist of 14, weekly sessions. Assessment of PTSD and related symptoms will be conducted at pre-treatment, mid treatment, post-treatment, and 3-, 6-, - and 12-month follow-up.

Primary Outcome

The CAPS-5 is a semi-structured interview to assess presence and severity of PTSD symptoms. The total score on the CAPS will be used as the primary outcome measure in this study. Total score range = 0-80; higher scores indicate greater symptom severity.

Interventions

  • BEHAVIORAL Group Cognitive Behavioral Treatment (GCBT)
  • BEHAVIORAL Present Centered Group Treatment

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2012-07-01
Est. Completion 2018-06-01
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01544088 record still lists

NCT01544088 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Group Cognitive Behavioral Treatment (GCBT) is the first listed.

NCT01544088 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01544088 about?

NCT01544088 is a clinical study titled "Group Treatment for PTSD: A Randomized Clinical Trial With Veterans". The purpose of this study is to examine whether group cognitive behavioral treatment (GCBT) is efficacious in the treatment of PTSD in a sample of male Veterans. Veterans with a primary diagnosis of chronic PTSD will be randomly assigned to either GCBT or a supportive group treatment condition. Both...

What is the current status of trial NCT01544088?

This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2012-07-01. Estimated completion is 2018-06-01.

What interventions are being tested in trial NCT01544088?

The interventions under investigation include: Group Cognitive Behavioral Treatment (GCBT) (BEHAVIORAL), Present Centered Group Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01544088?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01544088's enrollment target sits among peer trials

198 567th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05203328 · 198 participants · NA

    Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

  • NCT05426967 · 198 participants · NA

    rTMS for Military TBI-related Depression

  • NCT05561114 · 198 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

  • NCT05585190 · 198 participants · NA

    Stand Up for Your Health with a Sit-stand Desk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01544088, the US trial registry maintained by the National Library of Medicine. NCT01544088 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.